After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest its diagnostic and biosciences businesses as the company nears the finish ...
Zacks Investment Research on MSN
BD stock up post tie-up to expand hazardous drug contamination testing
Yesterday, Becton, Dickinson and Company BDX, popularly known as BD, announced a collaboration with ChemoGLO, a notable name ...
BD, a leading global medical technology company, and Frazier Healthcare Partners, a leading private equity firm focused exclusively on the healthcare sector, announced a definitive agreement for BD to ...
Read more about BD and INS Celebrate Nursing Excellence at the 13th Annual INS National Conference 2025 on Devdiscourse ...
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD said Wednesday CFO Chris DelOrefice will leave the ...
BD (Becton, Dickinson and Company), a leading global medical technology company, today will commemorate 55 years of manufacturing excellence at its Sumter, South Carolina facility, which throughout ...
FRANKLIN LAKES, N.J. & SAN DIEGO--(BUSINESS WIRE)--BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of laboratory automation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback